Walmart Opioid Settlement Reaches $50 Million

Walmart has agreed to pay $50 million to settle federal allegations that its pharmacies filled thousands of invalid opioid and other controlled-substance prescriptions dating back to June 2013, without admitting liability. The settlement follows a decade-long investigation that highlighted warnings from pharmacists about “pill mills” and internal emails prioritizing sales over compliance. As part of the deal, Walmart will implement strengthened oversight, including a reporting hotline for employees and patients, proactive monitoring of dispensing patterns, and formal processes to review prescribers under a new DEA oversight agreement. The Justice Department has stressed the measures are meant to tighten controls within one of the nation’s largest pharmacy chains. The original multi-billion-dollar potential liability was significantly narrowed by prior court rulings, with the remaining claims resolved by the $50 million settlement. Sources describe the settlement as part of ongoing DOJ enforcement of controlled-substance dispensing practices at major retailers.